{"count": 14121, "name": "Crossover study", "weight": 7.0, "id": 87813604, "level": 3}
{"count": 18822, "name": "Placebo-controlled study", "weight": 10.0, "id": 202061045, "level": 3}
{"count": 500, "name": "Parallel study", "weight": 0.0, "id": 2777246897, "level": 3}
{"count": 1116, "name": "Nicotine patch", "weight": 0.0, "id": 2776087441, "level": 3}
{"count": 892, "name": "Nocebo", "weight": 0.0, "id": 2778360308, "level": 3}
{"count": 110, "name": "Tanezumab", "weight": 0.0, "id": 2781203048, "level": 3}
{"count": 158, "name": "Addiction Research Center Inventory", "weight": 0.0, "id": 2777490815, "level": 3}
{"count": 655, "name": "Dose-ranging study", "weight": 0.0, "id": 2776312127, "level": 3}
{"count": 48, "name": "Ciramadol", "weight": 0.0, "id": 2780517169, "level": 3}
{"count": 119, "name": "Levomilnacipran", "weight": 0.0, "id": 2777556277, "level": 3}
{"count": 107, "name": "Run-in period", "weight": 0.0, "id": 2781204171, "level": 3}
{"count": 182, "name": "Active placebo", "weight": 0.0, "id": 2780627508, "level": 3}
{"count": 18, "name": "NicVAX", "weight": 0.0, "id": 2778893058, "level": 3}
{"count": 14, "name": "Response-rate ratio", "weight": 0.0, "id": 2776257033, "level": 3}
